Related Experiment Video
Updated: Jul 14, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Surgeons' opinions about enhanced recovery after surgery for retroperitoneal sarcoma: A survey
Luca Improta1, Chiara Maura Ciniselli2, Paolo Verderio2
1Soft Tissue Sarcoma Surgery, Fondazione Policlinico Universitario Campus Bio-medico, Rome 00128, Italy. luca.dr.improta@gmail.com.
Background:
Enhanced recovery after surgery (ERAS) programs provide recommendations for an optimized management of patients undergoing surgery. An ERAS program tailored on surgery for retroperitoneal sarcomas (RPS) may improve patient outcomes and it has still not been established.
Aim:
To determine how an ERAS program tailored to RPS surgery can be agreed upon, structured, and implemented.
Methods:
Twenty-five candidate items from existing ERAS programs, potentially relevant for RPS surgery, were identified via literature review and expert input. These were included in a questionnaire refined through cognitive interviews and pilot testing. Expert sarcoma surgeons rated each item's relevance and feasibility on a 6-point scale. The survey was recirculated after one year. Intra-observer reproducibility, inter-observer concordance, and agreement with the modal value of the most experienced participants were analyzed.
Results:
Thirteen sarcoma surgeons from 6 centers participated in the survey. Although surgeons agreed on several items, their overall concordance was low. After recirculating the survey, the intra-observer reproducibility was low. Interestingly, the median concordance with the reference increased for relevance and decreased for feasibility.
Conclusion:
Despite interest in ERAS for RPS, surgeon concordance on item relevance and feasibility remains low, underscoring the need for collaborative efforts toward a standardized, consensus-based protocol.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Healing II: Complications

